September 27, 2017 07:20 AM EDT
Pharma

For­mer Za­cks biotech an­a­lyst Napo­dano charged with fraud af­ter set­tling with SEC on in­sid­er trad­ing cas­es

John Carroll

Editor & Founder

Ja­son Napo­dano gained some wide­spread recog­ni­tion in a cer­tain group of biotech in­vestors and Twit­ter mavens while he was the se­nior biotech an­a­lyst at Za­cks …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times